REGN

NASDAQRegeneron Pharmaceuticals Inc
High Tide · 56Squeeze · Idle 18Neutral0 buys · $0Social · Quiet 0
$797.74
$-9.91 (-1.23%)
15-min delayed · Sep 10, 2:36 PMReal-time

Score summary

Buy
Analyst Ratings
22Ratings
15 Buy7 Hold0 Sell
Tide Score
56
High Tide · stable · Top 34% of universe (3998)
Outlook66High Tide · stable · Top 18% of universe (3999)
Squeeze Score
18
Idle ·
  • Days to cover3.15
  • Short interest3.30% of float
  • Borrow rate26.63%
  • Short interest trend-0.96% (30d)
Trend
Neutral
No clear trend (signals split)
Recent Smart Money
0 buys
Quiet · $0 · 14d · 9 super investors

Key statistics

Market Cap
$85.22B
52-week range
$553.32 – $852.03
46% from low
Day range
$797 – $809
Open $803.83
Volume
566k
vs 739k avg · 77%
P/E (TTM)
20.6
Fwd 13.7
Earnings
Oct 27
47d · est $12.89

Country ranks

US RankCountry rank populator pending
BW universe: US & CA common stocks only · ETFs and mutual funds excluded · Methodology →

Price chart with forecast cone and smart-money events

Wall Street Analyst Consensus

Wall Street Analyst Consensus
Aggregate of 22 third-party analyst opinions — not Quantellect advice.
12-mo median price target
$795
22 Wall St 12-month targets
High
$1,030
Average
$780
Low
$185
$151$379$608$836$1,064HIGH$1,030MEDIAN$795LOW$185Mar ’26NOW12-mo target
Recent price history, then Wall-Street analysts’ 12-month price targets (high / median / low) shown forward to the 12-month target levels. Targets are third-party analysts’ estimates of future performance — not guarantees, and not Quantellect recommendations. Past results do not guarantee future returns.
Per-analyst ratings are not yet available for this ticker.
Aggregate of third-party analysts’ published opinions, shown for information only — not Quantellect advice. The 67/100 Analyst Score (Buy) is Quantellect’ documented weighting of the rating distribution on the same 0–100 scale as the Tide / Squeeze / Trend / Money scores; the verdict label is derived from that score. Past results do not guarantee future returns. Source: aes.

Why Tide score breakdown

Smart-money feed

Social pulse

Smart-money modules

Catalysts ahead

Catalysts aheadEarnings Oct 27 (post-market, est EPS $12.89) · Annual shareholder meeting Jun 17 · Russell 1000 rebalance Jul 22 · DOJ CUDA hearing window Q3

Drill deeper

Not investment advice. Past results do not guarantee future returns. Scores, narratives, and historical-cohort statistics on this page are generated by Quantellect algorithms from public filings, market data, and AI synthesis, and describe the historical performance of structurally similar setups in our universe; failures are included. Data may be 15-minute delayed, contain errors, or be revised. Always do your own research and consult a licensed financial advisor before making investment decisions.